Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.
about
Transplant-associated thrombotic microangiopathy: opening Pandora's box.Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Remission of microangiopathy in transplanted thalassemic child.Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientThrombotic microangiopathy in haematopoietic cell transplantation: an update.Onco-nephrology: AKI in the cancer patient.Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.Advances in the understanding of acute graft-versus-host disease.Therapeutic apheresis for patients with cancer.Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Renal dysfunction following bone marrow transplantation.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
P2860
Q30235311-0251CA44-BCE7-4786-A79A-030CA786C460Q33375739-CF6EED60-D1C4-4D4B-87CB-D593C5D26A2AQ33417690-B73FAD7E-7726-42E8-AA73-7D3B565B8BFEQ33424902-B208C7B1-D860-4CBD-9A41-B0B6CAE4F3E2Q34316381-DA23E618-68F0-43F7-AB7D-B8D88D6E95CEQ34522746-30F978CA-5518-4F0B-8DA1-812283115AF2Q35098992-A0D0B582-8CE8-44BD-9811-6AF4B2F0C3A0Q36294351-AA285630-7EB3-439F-BE5E-27BD7C078796Q36445665-D4F25E7F-3E1B-4558-A350-51304C9F088CQ36759581-19183C40-C22C-4FBC-BB4F-8A017C7B948EQ38287610-B150BFF9-8460-4AED-9790-D078B35F1433Q38806679-C60E6C44-F358-4F6E-A861-E51915E92C44Q38944989-7665C27E-1921-4525-9D85-8ED0B3EBD6E4Q41992358-F4256905-1BC3-4A80-90B2-CD51B8D1EE50
P2860
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@ast
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@en
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@nl
type
label
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@ast
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@en
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@nl
prefLabel
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@ast
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@en
Replacement of calcineurin inh ...... ith graft-versus-host disease.
@nl
P2093
P2860
P356
P1476
Replacement of calcineurin inh ...... with graft-versus-host disease
@en
P2093
Gentilini C
Junghanss C
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705454
P407
P577
2006-09-01T00:00:00Z
P5875
P6179
1010202150